REVIEW ARTICLE
Year : 2008 | Volume
: 5 | Issue : 1 | Page : 66--80
Management of lamivudine resistance: An overview
Pietro Lampertico, Mauro Vigano, Massimo Colombo
1st Division of Gastroenterology, Fondazione IRCCS Maggiore Hospital Policlinico, Mangiagalli e Regina Elena, University of Milan, Via Francesco Sforza 35, 20122 Milano, Italy
Correspondence Address:
Pietro Lampertico
1st Division of Gastroenterology, Fondazione, Policlinico, Via Francesco Sforza 35, 20122 Milano
Italy
In the nineties, lamivudine (LMV) was the first nucleoside analog to be marketed for the treatment of patients with chronic hepatitis B virus (HBV). Following the advent of LMV, the management of patients with chronic hepatitis B, particularly those with advanced liver disease was markedly improved, with a substantial reduction in the rates of liver-related complications and mortality. In the face of excellent safety profile records of the drug, hepatologists had to face for the first time the issue of high rates of HBV resistance to therapy as the result of years of treatment of large cohorts of patients in the West and East. Initially considered no more than a virological problem, LMV resistance was later recognized to be a relevant clinical issue whose management requires specific therapeutic strategies. New, more active oral analogs have been marketed since, and new agents are to appear in the market scenario in the near future; however, LMV is still the number one prescribed anti-HBV agent worldwide for the treatment of chronic HBV patients, due to its limited cost, excellent safety and well predicted resistance profile.
How to cite this article:
Lampertico P, Vigano M, Colombo M. Management of lamivudine resistance: An overview.Hep B Annual 2008;5:66-80
|
How to cite this URL:
Lampertico P, Vigano M, Colombo M. Management of lamivudine resistance: An overview. Hep B Annual [serial online] 2008 [cited 2023 May 29 ];5:66-80
Available from: https://www.hepatitisbannual.org/article.asp?issn=0972-9747;year=2008;volume=5;issue=1;spage=66;epage=80;aulast=Lampertico;type=0 |
|
|
|
